Altis Labs’ Post

We’re excited to share that our latest research will be presented at ESMO 2025 in Berlin! This work highlights how IPRO can be applied as an early endpoint in oncology clinical trials, helping sponsors assess treatment effect earlier and more reliably. If you’ll be at #ESMO2025, let’s connect.

  • No alternative text description for this image

To view or add a comment, sign in

Explore content categories